The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Regional · European Union

[2026 update] EU-wide position versus national implementation

Solved
Solved by a.novak in post #2
Coming back to the opening post, because the follow-up matters more than the original answer. Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.

Jump to the accepted answer →

FI
f.ibarraTL2 Moderator19 Dec 2024#1

On the subject in the title: EU-wide position versus national implementation Working notes rather than a conclusion.

Documenting an access outcome, dated, because everything in this category expires.

As of February 2026, in my region, the position is as described below. I have linked the primary source rather than a summary of it, because the summaries are consistently a year behind.

If anyone can confirm or contradict this for their own region, please date your answer. An undated claim in this category is worse than no claim.

46 likes 19mo
AN
a.novakTL2 Moderator Solution30 Dec 2024#2

Coming back to the opening post, because the follow-up matters more than the original answer.

Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.

7 likes 19mo
DT
d.tammTL2 Moderator7 Jan 2025#3

Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular; others will not. Local pharmacy culture matters.

1 like 19mo
Promoted into the documentation commons. The content of this topic is maintained at Access notes: New Zealand, with named maintainers and a review date. The promotion was discussed in doc review. Corrections are best raised against the document, which is the version that gets kept current.

Suggested topics

TopicParticipantsRepliesViewsActivity
German, French and Dutch differences, compared
German, French and Dutch differences, compared — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
AKMMR 2 12k 10h
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
YISVCDAMB+70 74 7k 8mo
Coming back to: Cross-border purchase rules within the EU
Cross-border purchase rules within the EU Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…
JEDBNRPFFE+12 16 2.8k 11mo
Revisiting: German, French and Dutch differences, compared
Posting this under the heading it deserves: Revisiting: German, French and Dutch differences, compared Everything below is what sits behind that. A coverage question with the paperwork detail included, since…
ITKSTHEDS+90 99 32k 9mo
Reimbursement variation across member states
Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…
SFJSREBS+7 11 39k 3mo

Related topics — sharing the tags personal import, cost per milligram, formulary

TopicParticipantsRepliesViewsActivity
Price changes over 2025 and 2026, tabulated and dated — does this still hold?
Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated,…
WMCCDFKSDO+147 156 18k 3mo
Coverage for the indication versus for the drug
Coverage for the indication versus for the drug — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
AAAKEFHJG+70 79 18k 14mo
Prescription portability between countries
Prescription portability between countries — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
SGTLDCIAL+104 114 6.1k 3h
Price changes over 2025 and 2026, tabulated and dated
Posting this under the heading it deserves: Price changes over 2025 and 2026, tabulated and dated Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…
MAOCASMIDB+4 8 658 14mo
Reimbursement variation across member states
Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…
SFJSREBS+7 11 39k 3mo